Literature DB >> 32314171

Comparison of the diagnostic performance of imaging criteria for HCCs ≤ 3.0 cm on gadoxetate disodium-enhanced MRI.

Jieun Byun1,2, Sang Hyun Choi1, Jae Ho Byun3, So Jung Lee1, So Yeon Kim1, Hyung Jin Won1, Yong Moon Shin1, Pyo-Nyun Kim1.   

Abstract

BACKGROUND AND
PURPOSE: Imaging-based diagnostic systems play important roles in hepatocellular carcinoma (HCC). We aimed to compare the diagnostic performance of recently updated imaging criteria for HCCs ≤ 3.0 cm on gadoxetate disodium-enhanced magnetic resonance imaging (MRI).
METHODS: 493 nodules (399 HCCs, 24 other malignancies, 70 benign) 1.0-3.0 cm from 400 patients, including 322 male (mean age 59.3 ± 9.4 years) and 78 female (mean age 61.2 ± 9.0 years), at risk for HCC who underwent gadoxetate disodium-enhanced MRI between July 2015 and December 2016 were retrospectively evaluated. Final diagnosis was determined histopathologically or clinically. The sensitivity and specificity in diagnosing HCC of the latest versions of four imaging criteria [Liver Imaging Reporting and Data System (LI-RADS), European Association for the Study of the Liver (EASL), Asian Pacific Association for the Study of the Liver (APASL), Korean Liver Cancer Association-National Cancer Center (KLCA-NCC)] were compared using generalized estimating equations.
RESULTS: In 331 only pathologically diagnosed nodules, the sensitivities of both the APASL (86.8%) and KLCA-NCC criteria (85.4%) were significantly higher than the sensitivities of the EASL (71.8%) and LR-5 (71.1%) criteria (p < 0.001 for each pairwise comparison). However, the specificity of LR-5 was significantly higher than that of APASL (92.2% vs. 70.6%, respectively; p = 0.011) but did not differ significantly from the specificities of EASL (84.3%; p = 0.634) and KLCA-NCC (78.4%; p = 0.107).
CONCLUSION: Of the four international imaging criteria, LI-RADS and EASL showed high specificity but suboptimal sensitivity for diagnosing HCCs ≤ 3 cm. However, APASL and KLCA-NCC had a higher sensitivity but a lower specificity than LI-RADS and EASL.

Entities:  

Keywords:  Asian Pacific Association for the Study of the Liver; Carcinoma, Hepatocellular; Diagnostic algorithm; Diagnostic imaging; Diagnostic performance; European Association for the Study of the Liver; Korean Liver Cancer Association-National Cancer Center; Liver; Liver Imaging Reporting and Data System; Magnetic resonance imaging

Mesh:

Substances:

Year:  2020        PMID: 32314171     DOI: 10.1007/s12072-020-10040-2

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  6 in total

Review 1.  Up-to-Date Role of CT/MRI LI-RADS in Hepatocellular Carcinoma.

Authors:  Guilherme Moura Cunha; Victoria Chernyak; Kathryn J Fowler; Claude B Sirlin
Journal:  J Hepatocell Carcinoma       Date:  2021-05-31

Review 2.  Gadoxetate-Enhanced MRI as a Diagnostic Tool in the Management of Hepatocellular Carcinoma: Report from a 2020 Asia-Pacific Multidisciplinary Expert Meeting.

Authors:  Cher Heng Tan; Shu-Cheng Chou; Nakarin Inmutto; Ke Ma; RuoFan Sheng; YingHong Shi; Zhongguo Zhou; Akira Yamada; Ryosuke Tateishi
Journal:  Korean J Radiol       Date:  2022-05-09       Impact factor: 7.109

3.  Impact of the Liver Imaging Reporting and Data System on Research Studies of Diagnosing Hepatocellular Carcinoma Using MRI.

Authors:  Yura Ahn; Sang Hyun Choi; Jong Keon Jang; So Yeon Kim; Ju Hyun Shim; Seung Soo Lee; Jae Ho Byun
Journal:  Korean J Radiol       Date:  2022-03-08       Impact factor: 3.500

4.  Second-line Sonazoid-enhanced ultrasonography for Liver Imaging Reporting and Data System category 3 and 4 on gadoxetate-enhanced magnetic resonance imaging.

Authors:  Yeun-Yoon Kim; Ji Hye Min; Jeong Ah Hwang; Woo Kyoung Jeong; Dong Hyun Sinn; Hyo Keun Lim
Journal:  Ultrasonography       Date:  2022-01-28

5.  Comparison of international guidelines for diagnosis of hepatocellular carcinoma and implications for transplant allocation in liver transplantation candidates with gadoxetic acid enhanced liver MRI versus contrast enhanced CT: a prospective study with liver explant histopathological correlation.

Authors:  Devang Odedra; Ali Babaei Jandaghi; Rajesh Bhayana; Khaled Y Elbanna; Osvaldo Espin-Garcia; Sandra E Fischer; Anand Ghanekar; Gonzalo Sapisochin; Kartik S Jhaveri
Journal:  Cancer Imaging       Date:  2022-10-04       Impact factor: 5.605

6.  Accuracy of Various Forms of Contrast-Enhanced MRI for Diagnosing Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Chun Zhao; Hongyan Dai; Juwei Shao; Qian He; Wei Su; Peng Wang; Qiuyue Tang; Junren Zeng; Song Xu; Juanjuan Zhao; Shutian Xiang
Journal:  Front Oncol       Date:  2021-12-07       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.